142 related articles for article (PubMed ID: 37701945)
1. Emerging functions and applications of exosomes in oral squamous cell carcinoma.
Qie Y; Sun X; Yang Y; Yan T
J Oral Pathol Med; 2023 Nov; 52(10):886-894. PubMed ID: 37701945
[TBL] [Abstract][Full Text] [Related]
2. The Roles of Exosomes in the Diagnose, Development and Therapeutic Resistance of Oral Squamous Cell Carcinoma.
Shi S; Yu ZL; Jia J
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768288
[TBL] [Abstract][Full Text] [Related]
3. miR-365 (microRNA): Potential Biomarker in Oral Squamous Cell Carcinoma Exosomes and Extracellular Vesicles.
Coon J; Kingsley K; Howard KM
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32727045
[TBL] [Abstract][Full Text] [Related]
4. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3.
He L; Guo J; Fan Z; Yang S; Zhang C; Cheng B; Xia J
Cell Signal; 2023 Jun; 106():110635. PubMed ID: 36813147
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-induced tumor exosomes promote angiogenesis through miR-1825/TSC2/mTOR axis in oral squamous cell carcinoma.
Capik O; Gumus R; Karatas OF
Head Neck; 2023 Sep; 45(9):2259-2273. PubMed ID: 37449548
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived exosomes elicit cancer-associated fibroblasts shaping inflammatory tumor microenvironment in head and neck squamous cell carcinoma.
Mito I; Takahashi H; Kawabata-Iwakawa R; Horikawa M; Ida S; Tada H; Matsuyama T; Misawa K; Takeda S; Chikamatsu K
Oral Oncol; 2023 Jan; 136():106270. PubMed ID: 36462328
[TBL] [Abstract][Full Text] [Related]
7. M1-like tumor-associated macrophages activated by exosome-transferred THBS1 promote malignant migration in oral squamous cell carcinoma.
Xiao M; Zhang J; Chen W; Chen W
J Exp Clin Cancer Res; 2018 Jul; 37(1):143. PubMed ID: 29986759
[TBL] [Abstract][Full Text] [Related]
8.
Deng W; Meng Y; Wang B; Wang CX; Hou CX; Zhu QH; Tang YT; Ye JH
Cell Cycle; 2022 Aug; 21(16):1775-1783. PubMed ID: 35485349
[TBL] [Abstract][Full Text] [Related]
9. Exosome-mediated long noncoding RNA (lncRNA) PART1 suppresses malignant progression of oral squamous cell carcinoma via miR-17-5p/SOCS6 axis.
Du Y; Shuai Y; Wang H; Li H; Li Y
Turk J Med Sci; 2023 Jun; 53(3):630-639. PubMed ID: 37476905
[TBL] [Abstract][Full Text] [Related]
10. Analysis of mRNA-miRNA interaction network reveals the role of CAFs-derived exosomes in the immune regulation of oral squamous cell carcinoma.
Wang WZ; Cao X; Bian L; Gao Y; Yu M; Li YT; Xu JG; Wang YH; Yang HF; You DY; He YW
BMC Cancer; 2023 Jun; 23(1):591. PubMed ID: 37365497
[TBL] [Abstract][Full Text] [Related]
11. miR-200c-3p spreads invasive capacity in human oral squamous cell carcinoma microenvironment.
Kawakubo-Yasukochi T; Morioka M; Hazekawa M; Yasukochi A; Nishinakagawa T; Ono K; Kawano S; Nakamura S; Nakashima M
Mol Carcinog; 2018 Feb; 57(2):295-302. PubMed ID: 28981169
[TBL] [Abstract][Full Text] [Related]
12. PDGF-AA mediates mesenchymal stromal cell chemotaxis to the head and neck squamous cell carcinoma tumor microenvironment.
Watts TL; Cui R; Szaniszlo P; Resto VA; Powell DW; Pinchuk IV
J Transl Med; 2016 Dec; 14(1):337. PubMed ID: 27931212
[TBL] [Abstract][Full Text] [Related]
13. Exosomes in head and neck cancer. Updating and revisiting.
Rodríguez Zorrilla S; García García A; Blanco Carrión A; Gándara Vila P; Somoza Martín M; Gallas Torreira M; Pérez Sayans M
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1641-1651. PubMed ID: 31496355
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell-exosome-mediated matrix metalloproteinase 1 participates in oral leukoplakia and carcinogenesis by inducing angiogenesis.
Li S; Han Y; Lu M; Liu Z; Jin J; Guo Q; Wang Y; Liu H
J Oral Pathol Med; 2022 Aug; 51(7):638-648. PubMed ID: 35792829
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor/epidermal growth factor receptor signaling blockage inhibits tumor cell-derived exosome uptake by oral squamous cell carcinoma through macropinocytosis.
Sasabe E; Tomomura A; Liu H; Sento S; Kitamura N; Yamamoto T
Cancer Sci; 2022 Feb; 113(2):609-621. PubMed ID: 34874595
[TBL] [Abstract][Full Text] [Related]
16. Current Status, Opportunities, and Challenges of Exosomes in Oral Cancer Diagnosis and Treatment.
Liu H; Huang Y; Huang M; Huang Z; Wang Q; Qing L; Li L; Xu S; Jia B
Int J Nanomedicine; 2022; 17():2679-2705. PubMed ID: 35733418
[TBL] [Abstract][Full Text] [Related]
17. Application of a Persistent Heparin Treatment Inhibits the Malignant Potential of Oral Squamous Carcinoma Cells Induced by Tumor Cell-Derived Exosomes.
Sento S; Sasabe E; Yamamoto T
PLoS One; 2016; 11(2):e0148454. PubMed ID: 26849680
[TBL] [Abstract][Full Text] [Related]
18. Engineered exoASO-STAT6: a potent monotherapy for oral squamous cell carcinoma.
Jayaseelan VP; Paramasivam A
Future Oncol; 2022 Aug; 18(25):2767-2769. PubMed ID: 35766123
[No Abstract] [Full Text] [Related]
19. Exosomes derived from oral squamous cell carcinoma tissue accelerate diabetic wound healing.
Zhang M; Guo J; Xiang K; Chen J; Wang C; Jiang T; Kang Y; Xu X; Li J; Yang X; Chen Z
Am J Physiol Cell Physiol; 2023 Jun; 324(6):C1307-C1319. PubMed ID: 37154491
[TBL] [Abstract][Full Text] [Related]
20. Influence of tumor cell-derived TGF-β on macrophage phenotype and macrophage-mediated tumor cell invasion.
Maldonado LAG; Nascimento CR; Rodrigues Fernandes NA; Silva ALP; D'Silva NJ; Rossa C
Int J Biochem Cell Biol; 2022 Dec; 153():106330. PubMed ID: 36343916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
